TALE and TALEN genome editing technologies
Gene and Genome Editing · 2021-12 · 2 · 100007
DOI: 10.1016/j.ggedit.2021.100007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene and Genome Editing, 2021-12. Verfasst von Sebastian Becker und 1 weiteren Autor:innen. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BMBF Berlin, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
TALEN were the first easy-to-use genome editing technology and sparked the genome editing revolution. Their application in multiple species brought targeted mutagenesis to the attention of scientists worldwide. Key breakthrough successes of genome editing have since been achieved using TALEN, among these, the first commercialization of an edited crop and the first human cured from cancer. TALEN have since been largely replaced by the CRISPR technologies which are somewhat easier to build, much easier to multiplex, and have spawned multiple derived techniques. Nevertheless, the flexible and precise positioning of TALEN is unmatched, and thus they have continued to evolve to new functionalities. Here, we assemble essential facts, design guidelines as well as important past and exciting novel developments.
Förderung
- BMBF Berlin
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Becker, S., & Boch, J. (2021). TALE and TALEN genome editing technologies. Gene and Genome Editing, 2, 100007. https://doi.org/10.1016/j.ggedit.2021.100007
Vancouver
Becker S, Boch J. TALE and TALEN genome editing technologies. Gene and Genome Editing. 2021;2:100007. doi:10.1016/j.ggedit.2021.100007
BibTeX
@article{Becker2021,
author = {Becker, Sebastian and Boch, Jens},
title = {TALE and TALEN genome editing technologies},
journal = {Gene and Genome Editing},
year = {2021},
volume = {2},
pages = {100007},
doi = {10.1016/j.ggedit.2021.100007}
}
EUVIMED